Epidemiology & Population Health

The Epidemiology and Population Health Program monitors the impact of the HIV/AIDS epidemic in British Columbia.  Research from the program focuses on how antiretroviral therapy affects the health and well being of people living with HIV.  This includes identifying risks for HIV infection, monitoring access to antiretroviral therapy, and analyzing treatment programs. The program manages a variety of research cohorts and engages in numerous international research collaborations.

Recent studies from the Epidemiology and Population Health Program have helped identify the impact of baseline CD4 cell count and viral load on disease progression, the impact of adherence on disease progression, emerging drug toxicities of antiretroviral therapy, and the effect of socioeconomic status on access to antiretroviral therapy.

If you are looking for information about the Drug Treatment Program, please click here.

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below